Jones Financial Companies Lllp Novartis Ag Transaction History

Jones Financial Companies Lllp

  • $97.4 Billion
  • Q3 2024

A detailed history of Jones Financial Companies Lllp transactions in Novartis Ag stock. As of the latest transaction made, Jones Financial Companies Lllp holds 101,105 shares of NVS stock, worth $9.82 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
101,105
Previous 68,416 47.78%
Holding current value
$9.82 Million
Previous $7.28 Million 59.67%
% of portfolio
0.01%
Previous 0.01%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024
BUY
$106.13 - $120.89 $3.47 Million - $3.95 Million
32,689 Added 47.78%
101,105 $11.6 Million
Q2 2024

Aug 14, 2024
BUY
$92.57 - $107.37 $2.29 Million - $2.66 Million
24,775 Added 56.77%
68,416 $7.28 Million
Q1 2024

May 14, 2024
BUY
$95.27 - $108.47 $211,880 - $241,237
2,224 Added 5.37%
43,641 $4.22 Million
Q4 2023

Feb 13, 2024
BUY
$92.27 - $101.54 $56,930 - $62,650
617 Added 1.51%
41,417 $4.18 Million
Q3 2023

Nov 14, 2023
SELL
$94.73 - $105.13 $457,072 - $507,252
-4,825 Reduced 10.58%
40,800 $4.16 Million
Q2 2023

Aug 09, 2023
SELL
$92.52 - $104.91 $214,553 - $243,286
-2,319 Reduced 4.84%
45,625 $4.6 Million
Q1 2023

May 11, 2023
SELL
$80.03 - $92.81 $476,258 - $552,312
-5,951 Reduced 11.04%
47,944 $4.41 Million
Q4 2022

Feb 13, 2023
SELL
$75.55 - $92.52 $332,797 - $407,550
-4,405 Reduced 7.56%
53,895 $4.89 Million
Q3 2022

Nov 03, 2022
SELL
$74.61 - $87.26 $826,156 - $966,229
-11,073 Reduced 15.96%
58,300 $4.43 Million
Q2 2022

Aug 08, 2022
SELL
$80.52 - $93.75 $2.21 Million - $2.57 Million
-27,398 Reduced 28.31%
69,373 $5.86 Million
Q1 2022

May 02, 2022
SELL
$80.11 - $90.62 $3.68 Million - $4.16 Million
-45,893 Reduced 32.17%
96,771 $8.49 Million
Q4 2021

Feb 11, 2022
SELL
$79.7 - $88.13 $64,636 - $71,473
-811 Reduced 0.57%
142,664 $12.5 Million
Q3 2021

Nov 12, 2021
SELL
$81.78 - $95.14 $183,350 - $213,303
-2,242 Reduced 1.54%
143,475 $11.7 Million
Q2 2021

Aug 12, 2021
BUY
$85.24 - $94.15 $437,536 - $483,271
5,133 Added 3.65%
145,717 $13.3 Million
Q1 2021

Apr 30, 2021
BUY
$83.5 - $98.47 $133,433 - $157,355
1,598 Added 1.15%
140,584 $12 Million
Q4 2020

Feb 08, 2021
BUY
$78.07 - $94.43 $336,091 - $406,521
4,305 Added 3.2%
138,986 $13.1 Million
Q3 2020

Oct 29, 2020
BUY
$82.14 - $91.0 $445,116 - $493,129
5,419 Added 4.19%
134,681 $11.7 Million
Q2 2020

Jul 31, 2020
SELL
$80.93 - $91.1 $26,787 - $30,154
-331 Reduced 0.26%
129,262 $11.3 Million
Q1 2020

May 01, 2020
BUY
$70.67 - $99.01 $628,256 - $880,198
8,890 Added 7.37%
129,593 $10.7 Million
Q4 2019

Jan 21, 2020
BUY
$84.35 - $95.37 $67,395 - $76,200
799 Added 0.67%
120,703 $11.4 Million
Q3 2019

Oct 31, 2019
BUY
$85.54 - $94.26 $146,273 - $161,184
1,710 Added 1.45%
119,904 $10.4 Million
Q2 2019

Aug 02, 2019
BUY
$75.4 - $92.8 $547,027 - $673,264
7,255 Added 6.54%
118,194 $10.8 Million
Q1 2019

May 03, 2019
BUY
$75.32 - $86.15 $145,066 - $165,924
1,926 Added 1.77%
110,939 $10.7 Million
Q4 2018

Feb 11, 2019
SELL
$73.66 - $82.02 $110,269 - $122,783
-1,497 Reduced 1.35%
109,013 $9.35 Million
Q3 2018

Nov 08, 2018
BUY
$66.94 - $77.43 $83,741 - $96,864
1,251 Added 1.14%
110,510 $9.52 Million
Q2 2018

Aug 08, 2018
BUY
$64.91 - $73.36 $309,490 - $349,780
4,768 Added 4.56%
109,259 $8.25 Million
Q1 2018

May 11, 2018
BUY
$70.39 - $84.15 $516,732 - $617,745
7,341 Added 7.56%
104,491 $8.45 Million
Q4 2017

Feb 14, 2018
SELL
$72.33 - $77.64 $16,491 - $17,701
-228 Reduced 0.23%
97,150 $8.16 Million
Q3 2017

Nov 14, 2017
SELL
$74.14 - $77.27 $46,708 - $48,680
-630 Reduced 0.64%
97,378 $8.36 Million
Q2 2017

Aug 14, 2017
BUY
N/A
98,008
98,008 $8.18 Million

Others Institutions Holding NVS

# of Institutions
1,437
Shares Held
131M
Call Options Held
1.12M
Put Options Held
1.83M
View Full List

About NOVARTIS AG

NVS Quotes by TradingView
  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $209B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Jones Financial Companies Lllp Portfolio

Follow Jones Financial Companies Lllp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jones Financial Companies Lllp, based on Form 13F filings with the SEC.

News

Stay updated on Jones Financial Companies Lllp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email